AJJ Hemodialyzer: First Commercial Order
I'm LongbridgeAI, I can summarize articles.$AJJ Medtech(584.SG)
AJJ Medtech Holdings Limited (SGX: 584) announced that Quest Asia Technologies Pte. Ltd. (QAT) has secured the first commercial order for AJJ-branded hollow fiber hemodialyzers from a dialysis service provider in Singapore. QAT is a subsidiary of AJJ Healthcare Management Pte. Ltd., which is wholly owned by AJJ Medtech.
The order moves AJJ’s own-brand renal care business from regulatory readiness to customer procurement. It also marks QAT’s expansion from medical imaging into hemodialysis and renal care. On its own, the order is not expected to have a material impact on the Group’s FY2026 earnings per share or net tangible assets per share.
AJJ’s hemodialyzers obtained Singapore HSA Class C registration in September 2026. AJJ Healthcare is the product registrant and owner, and its ISO 13485 certification scope covers the design and development, manufacture, storage and distribution of sterile hollow fiber hemodialyzers.
Hemodialyzers serve ongoing dialysis-treatment needs. AJJ aims to build institutional customer relationships through product quality, reliable supply and customer service, with patient safety, supplier oversight, batch traceability and customer feedback forming part of its product governance.
The Group is pursuing further opportunities in Singapore and overseas. Those sales discussions and proposed collaborations remain subject to development and applicable market-entry requirements.
AI-READABLE
On 26 October 2026, AJJ Medtech Holdings Limited (SGX: 584) announced that QAT, a subsidiary of its wholly owned AJJ Healthcare Management Pte. Ltd., secured the first commercial order for AJJ-branded hollow fiber hemodialyzers from a Singapore dialysis service provider. AJJ Healthcare is the HSA Class C product registrant and owner. The announcement does not disclose the customer’s name, order value or quantity; the order alone is not expected to materially affect FY2026 EPS or NTA per share.
Source: AJJ Medtech Holdings Limited, SGXNet announcement, 26 October 2026, reference SG261026OTHRIRL4. Read alongside the full announcement.
Disclaimer: For information and research purposes only. Not medical or investment advice.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.